Surgery Partners (NASDAQ:SGRY) Stock Price Up 4.7%

Shares of Surgery Partners, Inc. (NASDAQ:SGRY) traded up 4.7% during mid-day trading on Wednesday . The stock traded as high as $30.04 and last traded at $29.68. 834,745 shares were traded during mid-day trading, a decline of 14% from the average session volume of 972,236 shares. The stock had previously closed at $28.34.

Analyst Upgrades and Downgrades

Several equities analysts have commented on the stock. Citigroup lowered their target price on shares of Surgery Partners from $42.00 to $38.00 and set a “buy” rating on the stock in a research report on Wednesday, May 8th. Macquarie assumed coverage on Surgery Partners in a report on Friday, June 28th. They set an “outperform” rating and a $31.00 price target on the stock. Cantor Fitzgerald restated an “overweight” rating and issued a $43.00 price objective on shares of Surgery Partners in a research note on Tuesday, July 9th. Finally, Benchmark reiterated a “buy” rating and issued a $50.00 target price on shares of Surgery Partners in a research note on Wednesday, May 1st. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $40.14.

Surgery Partners Trading Up 4.1 %

The company has a debt-to-equity ratio of 0.92, a quick ratio of 1.56 and a current ratio of 1.71. The stock has a market capitalization of $4.07 billion, a price-to-earnings ratio of 34.51, a PEG ratio of 2.25 and a beta of 2.78. The company’s 50 day moving average is $25.66 and its 200 day moving average is $28.11.

Surgery Partners (NASDAQ:SGRY) last released its earnings results on Tuesday, May 7th. The company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.02. Surgery Partners had a net margin of 0.02% and a return on equity of 3.65%. The business had revenue of $717.40 million during the quarter, compared to analysts’ expectations of $707.66 million. On average, research analysts forecast that Surgery Partners, Inc. will post 0.88 EPS for the current fiscal year.

Insider Transactions at Surgery Partners

In other news, insider Danielle Burkhalter sold 6,000 shares of the stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $26.39, for a total value of $158,340.00. Following the completion of the transaction, the insider now owns 30,354 shares in the company, valued at approximately $801,042.06. The sale was disclosed in a filing with the SEC, which is available at this link. 2.30% of the stock is owned by insiders.

Institutional Trading of Surgery Partners

A number of large investors have recently bought and sold shares of the stock. Mesirow Institutional Investment Management Inc. raised its stake in shares of Surgery Partners by 12.4% in the fourth quarter. Mesirow Institutional Investment Management Inc. now owns 3,388 shares of the company’s stock valued at $108,000 after acquiring an additional 373 shares during the last quarter. Natixis Advisors L.P. boosted its stake in Surgery Partners by 8.6% in the fourth quarter. Natixis Advisors L.P. now owns 11,735 shares of the company’s stock worth $375,000 after purchasing an additional 934 shares in the last quarter. ProShare Advisors LLC grew its holdings in shares of Surgery Partners by 7.8% during the first quarter. ProShare Advisors LLC now owns 13,588 shares of the company’s stock worth $405,000 after purchasing an additional 986 shares during the last quarter. DekaBank Deutsche Girozentrale increased its stake in shares of Surgery Partners by 102.0% in the first quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock valued at $80,000 after buying an additional 1,375 shares in the last quarter. Finally, Principal Financial Group Inc. raised its holdings in shares of Surgery Partners by 16.3% in the first quarter. Principal Financial Group Inc. now owns 10,073 shares of the company’s stock valued at $300,000 after buying an additional 1,409 shares during the last quarter.

About Surgery Partners

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.